DRREDDY vs JIOFIN: Stock Comparison
Jio Financial Services Ltd is the larger company by market capitalisation. Dr Reddys Laboratories Ltd shows a lower P/E, a higher ROE and a higher dividend yield, while Jio Financial Services Ltd shows faster revenue growth and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
DRREDDY leads 5; JIOFIN leads 7 of 12
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | DRREDDY | JIOFIN |
|---|---|---|
| Sector | Healthcare | Financial Services |
| Industry | Pharmaceuticals | Investment Company |
Price
| Metric | DRREDDY | JIOFIN |
|---|---|---|
| Live Price | ₹1,174.7 | ₹244 |
| Day Change | -0.45% | -0.25% |
| Volume | 12.47 L | 55.83 L |
| 52-Week High | ₹1,414.9 | ₹329.4 |
| 52-Week Low | ₹1,101 | ₹223.3 |
| Distance from 52W High | -16.98% | -25.93% |
Valuation
| Metric | DRREDDY | JIOFIN |
|---|---|---|
| Market Cap | ₹98,417 Cr | ₹1.61 L Cr |
| P/E Ratio | 30.43x | 76.16x |
| P/B Ratio | 2.59x | 1.16x |
| EPS | ₹39.66 | ₹3.21 |
| Book Value | ₹460.31 | ₹211.44 |
| Dividend Yield | 0.68% | 0.23% |
Growth
| Metric | DRREDDY | JIOFIN |
|---|---|---|
| Revenue Growth (TTM YoY) | -11.6% | 39.4% |
| EPS Growth (TTM YoY) | -86.2% | -14% |
| Qtr Sales Growth | -11.5% | 106% |
| Qtr Profit Growth | -86.1% | -13.9% |
Profitability & Leverage
Debt-to-equity is shown for reference only — it is not a like-for-like metric for banks and financials.| Metric | DRREDDY | JIOFIN |
|---|---|---|
| ROE | 11.2% | 1.19% |
| ROCE | 13% | 1.86% |
| Net Margin | 12.76% | 51.8% |
| Operating Margin | 19.2% | 65.6% |
| Debt to Equity | 0.2x | 0.16x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | DRREDDY | JIOFIN |
|---|---|---|
| Promoter Holding | 26.64%▲ 0.01 pp | 49.13%▲ 2.01 pp |
| FII Holding | 32.07%▼ 1.01 pp | 11.27%▼ 1.04 pp |
| DII Holding | 31.74%▲ 1.02 pp | 13.36%▼ 1 pp |
| Public Holding | 9.35%▲ 0.02 pp | 26.16%▲ 0.04 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Dr Reddys Laboratories Ltd and Jio Financial Services Ltd.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.